Publications | Lund University Publications

1 – 10 of 11

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Friedlander%2C+Michael%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Friedlander%2C+Michael%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2020
Mark Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers : Results from the BRCA1 and BRCA2 cohort consortium
Li, Hongyan ; Terry, Mary Beth ; Antoniou, Antonis C. ; Phillips, Kelly Anne ; Kast, Karin ; Mooij, Thea M. ; Engel, Christoph ; Nogues, Catherine ; Stoppa-Lyonnet, Dominique and Lasset, Christine , et al. (2020) In Cancer Epidemiology Biomarkers and Prevention 29(2). p.368-378
- Contribution to journal › Article
2018
Mark Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy
Friedlander, Michael ; Rau, J. ; Lee, C. K. ; Meier, W. ; Lesoin, A. ; Kim, J. W. ; Poveda, A. ; Buck, M. ; Scambia, G. and Shimada, M. , et al. (2018) In Annals of Oncology 29(3). p.737-743
- Contribution to journal › Article
Mark Oral Contraceptive Use and Breast Cancer Risk : Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study
Schrijver, Lieske H ; Olsson, Håkan ^LU ; Phillips, Kelly-Anne ; Terry, Mary Beth ; Goldgar, David E ; Kast, Karin ; Engel, Christoph ; Mooij, Thea M ; Adlard, Julian and Barrowdale, Daniel , et al. (2018) In JNCI Cancer Spectrum 2(2).
- Contribution to journal › Article
2016
Mark Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy.
Domchek, Susan M ; Aghajanian, Carol ; Shapira-Frommer, Ronnie ; Schmutzler, Rita K ; Audeh, M William ; Friedlander, Michael ; Balmaña, Judith ; Mitchell, Gillian ; Fried, Georgeta and Stemmer, Salomon M , et al. (2016) In Gynecologic Oncology 140(2). p.199-203
- Contribution to journal › Article
2015
Mark Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation.
Kaufman, Bella ; Shapira-Frommer, Ronnie ; Schmutzler, Rita K ; Audeh, M William ; Friedlander, Michael ; Balmaña, Judith ; Mitchell, Gillian ; Fried, Georgeta ; Stemmer, Salomon M and Hubert, Ayala , et al. (2015) In Journal of Clinical Oncology 33(3). p.134-244
- Contribution to journal › Article
Mark Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Peterlongo, Paolo ; Chang-Claude, Jenny ; Moysich, Kirsten B ; Rudolph, Anja ; Schmutzler, Rita K ; Simard, Jacques ; Soucy, Penny ; Eeles, Rosalind A ; Easton, Douglas F and Hamann, Ute , et al. (2015) In Cancer Epidemiology Biomarkers & Prevention 24(1). p.308-316
- Contribution to journal › Article
2013
Mark Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Phillips, Kelly-Anne ; Milne, Roger L ; Rookus, Matti A ; Daly, Mary B ; Antoniou, Antonis C ; Peock, Susan ; Frost, Debra ; Easton, Douglas F ; Ellis, Steve and Friedlander, Michael L , et al. (2013) In Journal of Clinical Oncology 31(25). p.3091-3091
- Contribution to journal › Article
Mark Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
Couch, Fergus J. ; Wang, Xianshu ; McGuffog, Lesley ; Lee, Andrew ; Olswold, Curtis ; Kuchenbaecker, Karoline B. ; Soucy, Penny ; Fredericksen, Zachary ; Barrowdale, Daniel and Dennis, Joe , et al. (2013) In PLoS Genetics 9(3).
- Contribution to journal › Article
2011
Mark Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer
Domchek, Susan M. ; Mitchell, Gillian ; Lindeman, Geoffrey J. ; Tung, Nadine M. ; Balmana, Judith ; Isakoff, Steven J. ; Schmutzler, Rita ; Audeh, M. William ; Loman, Niklas ^LU and Scott, Clare , et al. (2011) In Journal of Clinical Oncology 29(32). p.4224-4226
- Contribution to journal › Debate/Note/Editorial
2010
Mark Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Tutt, Andrew ; Robson, Mark ; Garber, Judy E. ; Domchek, Susan M. ; Audeh, M. William ; Weitzel, Jeffrey N. ; Friedlander, Michael ; Arun, Banu ; Loman, Niklas ^LU and Schmutzler, Rita K. , et al. (2010) In The Lancet 376(9737). p.235-244
- Contribution to journal › Article

« previous
1
2
next »

your query:: Remove author: Friedlander, Michael